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Prevalence of arterial hypertension and risk factors among people with 
acquired immunodeficiency syndrome*
Objectives: to verify the prevalence of arterial hypertension and its risk factors among people 
with acquired immunodeficiency syndrome under antiretroviral therapy. Method: cross-
sectional study with 208 patients. Data collection was conducted through interviews using a 
form containing data on sociodemographic, clinical and epidemiological aspects, hypertension 
risk factors, blood pressure, weight, height, body mass index and abdominal circumference. 
Mean, standard deviation, odds ratio and confidence interval were calculated, t-test and Chi-
square test were used, considering P < 0.05 as statistically significant. Hypertension associated 
variables were selected for logistic regression. Results: patients were male (70.7%), self-
reported as mixed-race (68.2%), had schooling between 9 and 12 years of study (46.6%), 
had no children (47.6%), were single (44.2%), in the sexual exposure category (72.1%) and 
heterosexual (60.6%). The prevalence of people with acquired immunodeficiency syndrome and 
arterial hypertension was 17.3%. Logistic regression confirmed the influence of age greater 
than 45 years, family history of hypertension, being overweight and antiretroviral therapy for 
more than 36 months for hypertension to occur. Conclusion: the prevalence of hypertension was 
17.3%. Patients with acquired immunodeficiency syndrome and hypertension were older than 
45 years, had family history of hypertension, were overweight and under antiretroviral therapy 
for more than 36 months.
Descriptors: Acquired Immunodeficiency Syndrome; HIV; Hypertension; Nursing; Health 
Promotion; Antiretroviral Therapy, Highly Active.
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Introduction
Acquired immunodeficiency syndrome (aids) 
represents one of the greatest contemporary health 
problems, due to its pandemic character and severity, 
being a challenge due to the nonexistence of an 
effective treatment that results in cure, in addition 
to socioeconomic barriers that interfere with the 
adherence to the treatment regimen(1). Antiretroviral 
therapy (ART) is the only treatment available that 
provides the increased survival and decreases mortality, 
characterizing the disease as chronic. Thus, the 
treatment focus has shifted from the disease itself and 
immunodeficiency-related opportunistic infections to 
long-term problems caused by the effects of the human 
immunodeficiency virus (HIV) and ART, which includes 
toxicity, drug interactions or resistance to these drugs(2).
Moreover, an increase in the frequency of 
cardiovascular disease in people with aids has 
been observed, especially hypertension, which is 
characterized by systolic blood pressure greater than 
or equal to 140 mmHg and diastolic blood pressure 
greater than or equal to 90 mmHg(3-4). However, it is 
not known whether this is related to increases in the 
patients’ survival rate, whom now reach older ages; 
if it is related to the HIV infection itself; if it can be 
assigned to ART as a result of adverse drug events; or, 
if all of these factors contribute synergistically to the 
occurrence of cardiovascular diseases(2-5).
Studies also show that many people with aids have 
unhealthy lifestyles regarding their feeding, exercise, 
alcohol consumption and smoking habits, in addition 
to traditional hypertension risk factors, which include 
advanced age, male gender, African ascent, high body 
mass index (BMI) and high cholesterol(3,6). Thus, efforts 
to reduce cardiovascular risk in patients using ART 
should focus on prevention and control of hypertension, 
because this is a common, known and modifiable 
predictive factor(3-4).
Data on prevalence of hypertension among people 
with aids are variable. Although some authors report 
higher prevalence of hypertension in this group(7-8), 
when compared to uninfected individuals, other 
studies present similar prevalence of hypertension 
among men and women with aids and individuals 
uninfected by HIV(9-10).
There are justifications for a study on the risk factors 
for hypertension and its prevalence among aids patients. 
The first is that the prevention of cardiovascular diseases 
is important for these patients due to predisposition, 
the HIV infection, the use of ART and aging due to the 
increase in the survival rate(4,11). In addition, detection, 
treatment and control of hypertension are fundamental 
to reduce cardiovascular diseases, since they increase 
the number of hospitalizations and lead to high medical 
and socioeconomic costs(12).
The efforts of health professionals, scientific 
community and government agencies are essential 
to treat and control hypertension. Such studies are 
important so health care professionals can perform 
preventive and treatment measures of cardiovascular 
diseases, given that health promotion practices are 
critical for these patients, whom require specialized care 
to maintain their quality of life.
Given this context, an interdisciplinary approach 
is required in the follow-up of people living with HIV/
aids, mainly due to changes in lifestyle and frequent 
monitoring. Among health professionals, nurses have 
a strategic role and provide care to aids patients in 
different health areas. The nurse must comprehend 
the disorder, improve routine practices, adopt 
preventive measures to avoid the accidental exposure 
to HIV, and acquire knowledge of clinical treatment in 
its different aspects(13).
In this perspective, considering the increase in the 
survival rate of people with aids by the implementation 
of ART, the known actions of HIV on the body, the 
adverse events of ART and the increase of cardiovascular 
diseases in these individuals showed by the studies 
cited – having hypertension as one of its primary 
precursors–, the general objective of this study was to 
verify the prevalence of hypertension and its risk factors 
among people with aids under antiretroviral therapy. 
This research can direct health practices of nurses and 
other professionals who provide care for these patients.
Method
This is a cross-sectional, descriptive and quantitative 
study, developed in the infectious diseases outpatient 
clinic of the University Hospital Walter Cantídio of the 
Universidade Federal do Ceará (UFC), in Fortaleza, 
Ceará, Brazil, from August 2015 to August 2017. The 
study population was constituted by aids patients whom 
were treated in the clinic.
A sample was scaled to estimate the prevalence of 
aids patients served in the outpatient clinic and who had 
hypertension and its risk factors, with 95% confidence 
that the estimation error does not exceed 5%, considering 
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that such prevalence is unknown in the population, 
being stipulated in 50% (presumed prevalence) – as it 
provides the largest sample size –, and that there were 
450 patients under ART being served during the study 
period. For such, the following expression was used: 
n = z2 × p × (1 – p) × N / ε2 × (N – 1) + z2 × p × (1 – p). 
In this formula, z2 is equal to the value of the z statistic 
(1.96) for the adopted degree of confidence (95%) 
and p, N and ε correspond to the assumed prevalence 
(0.50), to the population (450) and to the tolerable error 
(0.05), respectively. Thus, a sample of 208 patients was 
calculated.
Inclusion criteria were people with aids of both 
genders, aged 18 years or older, who were under ART 
for at least three months and who were in outpatient 
follow-up. Exclusion criteria were pregnancy, mental 
illness, persons deprived of their liberty, people living 
in collective shelters or any other condition capable of 
interfering in an individual’s participation in the research.
The sampling strategies adopted were non-
probability and convenience. Patients were invited to 
participate in the study when they attended to routine 
consultations in the outpatient clinic. Those who agreed 
to participate in the research signed an informed 
consent form, and were interviewed for approximately 
40 minutes in a private environment.
A form divided into two parts was used: I. 
sociodemographic, epidemiological and clinical variables 
(age, sex, skin color, schooling, marital status, number 
of children, religion, occupational situation, monthly 
family income, category of exposure, sexual orientation, 
presence of lipodystrophy, use of anti-retroviral drugs, 
CD4+ T lymphocytes count, viral load, time of infection, 
time of use of ART); II. variables related to hypertension 
and its risk factors (salt consumption, use of salt shaker 
on the table, use of alcohol, smoking, exercising, 
personal and family background of hypertension, daily 
consumption of fruits, vegetables, fried and fatty 
foods, hypertension diagnosis and antihypertensive 
drugs used), blood pressure measurement (normal: 
≤ 120/80 mmHg; hypertension: ≥ 140/90 mmHg), 
weight, height, body mass index (normal: < 25 kg/m2; 
overweight: ≥ 25 kg/m2;obesity: ≥ 30 kg/m2) and waist 
circumference (normality in men and women, < 94 and 
< 80 cm, respectively).
Part I of the form had already been validated in 
previous studies(14-15), the data on hypertension and its 
risk factors were added to it. Prior to data collection, the 
complete form was applied to 20 aids patients whom 
were not part of the sample. The study researchers 
were trained to apply the form, considering subjective 
and objective data, using standard operating procedures 
for measuring blood pressure, weight, height, BMI and 
waist circumference and to set the normality parameters 
of the findings(16).
The mean and standard deviation were calculated 
in the statistical analysis. For comparisons between 
hypertensive and normotensive subjects, the t-test was 
used for unpaired variables. A P < 0.05 was considered 
a statistically significant value. Absolute and relative 
frequencies were determined. The association of 
sociodemographic and clinical factors and the occurrence 
of hypertension, which is the primary outcome, 
were evaluated by the Chi-square test, considering 
P < 0.05 as statistically significant. The strength of 
such association also was evaluated by determining 
the odds ratio and its 95% confidence interval. 
Explanatory variables associated with hypertension 
at 20% significance level (P < 0.2) were selected to 
be part of the logistic regression model, identifying 
those that, independently, were factors associated with 
hypertension. For such, the stepwise backward method 
was used. The criterion for removing variables from 
the model was defined by the Wald test. This analysis 
was used to calculate the adjusted odds ratio, accuracy 
(95% confidence interval) and significance (Wald’s test) 
of the estimate. The Statistical Package for the Social 
Sciences (SPSS) software 20.0 version was used for the 
statistical procedures.
The project was approved by the Research Ethics 
Committee of UFC on March 12, 2015, under opinion nº 
983.195. All participants signed the informed consent 
form. The participants’ privacy was maintained and 
the research data used only for scientific purposes. 
This study also considered the STROBE Statement 
guidelines.
Results
Of the 208 people with aids evaluated, most were 
male (70.7%), self-reported as mixed-race (68.2%), 
schooling from 9 to 12 years of study (46.6%), single 
(44.2%) or married (41.1%) and had no children 
(47.6%). Most reported being Catholic (66.4%), were 
employed at the time of the study (55.3%) and had 
monthly family income greater than three minimum 
wages (26.4%). Most were in the sexual exposure 
category (72.1%), straight (60.6%) and 88 had 
lipodystrophy (42.3%). Data presented in Table 1.
www.eerp.usp.br/rlae
4 Rev. Latino-Am. Enfermagem 2018;26:e3066.
Table 1 – Sociodemographic and epidemiological 
characterization of people with acquired 
immunodeficiency syndrome (n = 208). Fortaleza, 
Ceará, Brazil, 2015-2017
Sociodemographic and epidemiological 
variables N %
Sex
Male 147 70.7
Female 61 29.3
Skin color
White 48 23.1
Black 18 8.7
Mixed-race 142 68.2
Schooling (years of study)
≤ 8 years (illiterate or some elementary/middle 
school) 60 28.9
9 – 12 years (Elementary or High School) 97 46.6
≥ 13 years (higher education) 51 24.5
Marital status
Single 92 44.2
Married 86 41.4
Divorced/widowed 30 14.4
Number of children
None 99 47.6
1 – 2 67 32.2
≥ 3 42 20.2
Religion
Catholic 138 66.4
Evangelical 36 17.3
Others (no religion, Spiritualist, Umbanda) 34 16.3
Occupational situation
Employed 115 55.3
Unemployed 54 25.9
Retired/temporary retirement 39 18.8
Monthly family income in number of minimum 
wages*
< 1 47 22.6
1 – 2 70 33.7
2 – 3 36 17.3
> 3 55 26.4
Exposure category
Sexual 150 72.1%
Blood/transfusion 6 2.9%
Puncture or cutting accident 1 0.5%
Unknown 51 24.5%
Sexual orientation
Heterosexual 126 60.6%
Homosexual 64 30.8%
Bisexual 18 8.6%
Lipodystrophy
Yes 88 42.3%
No 120 57.7%
*Current minimum wage in Brazil in the study period – 2015: R$ 788.00; 
2016: R$ 880.00; 2017: R$ 937.00
Among the antiretroviral drugs used were: 
lamivudine (195; 94%), tenofovir (125; 60.1%), efavirenz 
(116; 55.8%), zidovudine (93; 44.7%), atazanavir (42; 
20.2%), lopinavir (27; 13%), nevirapine (11; 5.3%) 
and raltegravir (6; 2.9%). Regarding the values of HIV-
related laboratory tests, considering the 208 patients, 
was found: CD4+ T lymphocytes (cells/mm3) (mean ± 
standard deviation: 599.144 ± 377.960; minimum value: 
29; maximum value: 3.179) and viral load (copies/ml) 
(mean ± standard deviation: 18.027.086 ± 104.133.463; 
minimum value: 0; maximum value: 1.058.662).
Most people with aids reported moderate salt 
consumption (56.7%) and 26 patients (12.5%) used 
a salt shaker on the table during meals. Regarding 
food, most patients reported daily consumption of 
fruits (92.3%), vegetables (91.3%), fried and fatty 
foods (78.8%). A considerable number of patients used 
alcohol (40.4%), 54 (26%) had stopped smoking and 
19.7% were smokers. Most did not practice physical 
exercises (61.5%), 141 (67.8%) had family history 
of hypertension, and the main personal history was 
diabetes (6.7%) (Table 2).
Table 2 – Risk factors for hypertension presented by 
people with acquired immunodeficiency syndrome 
(n = 208). Fortaleza, Ceará, Brazil, 2015-2017
Risk factors for arterial hypertension N %
Salt consumption
High 28 13.5
Moderate 118 56.7
Low 62 29.8
Presence of salt shaker on the table
Yes 26 12.5
No 182 87.5
Consumption of alcoholic beverages
Yes 84 40.4
No 124 59.6
Smoking habit
Never smoked 113 54.3
Stopped smoking 54 26.0
Smoker 41 19.7
Performance of physical activities
Yes 80 38.5
No 128 61.5
Family history of hypertension
Yes 141 67.8
No 67 32.2
Personal background
Diabetes 14 6.7
Cerebrovascular accident 5 2.4
Myocardial Infarction 4 1.9
Angina 1 0.5
Daily consumption of fruits
Yes 192 92.3
No 16 7.7
Daily consumption of vegetables
Yes 190 91.3
No 18 8.7
Daily consumption of fried and fatty foods
Yes 164 78.8
No 44 21.2
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In the sample of 208 patients, 36 had hypertension, 
with 17.3% prevalence (95% confidence interval: 
12.1 – 22.4%). The antihypertensive drugs used 
were: losartan (18; 50%), hydrochlorothiazide (11; 
30.6%), enalapril (8; 22.2%), propranolol (4; 11.1%), 
atenolol (4; 11.1%), amlodipine (3; 8.3%), captopril 
(2; 5.6%), carvedilol (1; 2.8%), chlortalidone (1; 
2.8%), furosemide (1; 2.8%) and metoprolol (1; 2.8%). 
The association between sex and hypertension was 
evaluated by the Chi-square test. The t-test was used 
for unpaired data to compare the two strata in relation 
to other variables. It was found that people with aids 
and hypertension had higher mean age (P < 0.001), 
greater waist circumference (P < 0.001), longer time 
of infection (P = 0.005) and longer time of use of ART 
(P = 0.002) (Table 3).
The association between the risk factors for 
hypertension and the occurrence of hypertension was 
evaluated by the Chi-square test, and by determining 
the odds ratio and its respective 95% confidence 
interval (95% CI). Table 4 shows the data expressed 
as number of cases (n) and percentage (%). It was 
observed that people with aids had higher chances of 
presenting hypertension when the age was greater than 
45 years (P = 0.003), had family history of hypertension 
(P = 0.003), were overweight (P = 0.024), had increased 
waist circumference (P = 0.013) and time of use of ART 
greater than 36 months (P < 0.001) (Table 4).
Table 3 – Sociodemographic and clinical characteristics of people with acquired immunodeficiency syndromed stratified 
according to the presence of arterial hypertension (n = 208). Fortaleza, Ceará, Brazil, 2015-2017
Characteristics
Systemic arterial hypertension
Significance 
Present Absent
Age (years, mean ± SD*) 48.8 ± 12.0 39.7 ± 10.6 P < 0.001
Sex, n (%)
Male 27 (75.0%) 120 (69.7%) P = 0.531
Female 9 (25.0%) 52 (30.2%)
Body mass index (kg†/m2‡, mean ± SD*) 27.0 ± 4.3 25.4 ± 6.9 P = 0.193
Waist circumference (cm§, mean ± SD*) 96.2 ± 9.9 88.2 ± 11.2 P < 0.001
Time of HIV infection (years, mean ± SD*) 8.6 ± 4.0 6.3 ± 4.5 P = 0.005
Time of use of ART|| (months, mean ± SD*) 92.7 ± 44.6 62.6 ± 54.0 P = 0.002
CD4+ T lymphocytes count (cells/mm3¶, mean ± SD*) 612.4 ± 281.6 596.3 ± 395.8 P = 0.817
*SD: standard deviation; †kg: kilogram; ‡m2: square meter; §cm: centimeter; ||ART: antiretroviral therapy; ¶mm3: cubic milimeters
Table 4 – Associated factors with hypertension in people with acquired immunodeficiency syndrome in use of 
antiretroviral therapy according to the presence (n = 36) or absence (n = 172) of arterial hypertension. Fortaleza, 
Ceará, Brazil, 2015-2017
Risk factors for arterial hypertension
Hypertension 
OR* 95% CI† Significance  (Chi-square test)Present Absent
n % n %
Age
> 45 years 20 55.5 51 29.6 2.97 1.42 – 6.18 P = 0.003
≤ 45 years 16 44.4 121 70.3 1
Sex
Male 27 75.0 120 69.7 1.30 0.57 – 2.96 P = 0.531
Female 9 25.0 52 30.2 1
Family history of hypertension
Yes 32 88.8 110 63.9 4.51 1.52 – 13.4 P = 0.003
No 4 11.1 62 36.0 1
Smoking
Yes 12 33.3 83 48.2 0.54 0.25 – 1.14 P = 0.102
No 24 66.6 89 51.7 1
Consumption of alcohol
Yes 15 41.6 69 40.1 1.07 0.51 – 2.21 P = 0.863
No 21 58.3 103 59.8 1
(continue...)
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Logistic regression analysis was used to determine the 
adjusted odds ratio, as well as the accuracy (95% confidence 
interval) and significance (Wald’s test) of the estimate. 
The variables that integrated the logistic regression model 
(P < 0.2) were: age, family history of hypertension, 
smoking, overweight, obesity, waist circumference, time 
of HIV diagnosis and time of use of ART. The results of 
the analyses showed that in the considered sample, the 
risk of hypertension increased with the following variables: 
age greater than 45 years (P = 0.01), family history of 
hypertension (P = 0.005), being overweight (P = 0.019) 
and time of use of ART (P = 0.002) (Table 5).
Risk factors for arterial hypertension
Hypertension 
OR* 95% CI† Significance  (Chi-square test)Present Absent
n % n %
Physical activity
Yes 13 36.1 67 38.9 0.89 0.42 – 1.87 P = 0.750
No 23 63.8 105 61.0 1
Overweight (BMI‡ ≥ 25)
Yes 24 66.6 79 45.9 2.35 1.11 – 5.01 P = 0.024
No 12 33.3 93 54.0 1
Obesity (BMI‡ ≥ 30)
Yes 8 22.2 22 12.7 1.95 0.79 – 4.81 P = 0.143
No 28 77.7 150 87.2 1
Waist circumference
Increased 14 38.8 34 19.7 2.58 1.20 – 5.57 P = 0.013
Normal 22 61.1 138 80.2 1
CD4+ T lymphocytes count
< 350 cells/mm3§ 7 19.4 41 23.8 0.77 0.31 – 1.89 P = 0.569
≥ 350 cells/mm3§ 29 80.5 131 76.1 1
Time of diagnosis of HIV|| infection
> 3 years 34 94.4 142 82.5 3.59 0.82 – 15.77 P = 0.072
≤ 3 years 2 5.5 30 17.4 1
Time of antiretroviral therapy
> 36 months 31 86.1 91 52.9 5.52 2.05 – 14.86 P < 0.001
≤ 36 months 5 13.8 81 47.0 1
*OR: odds ratio; †CI: confidence interval; ‡BMI: body mass index; §mm3: cubic millimeters; ||HIV: human immunodeficiency virus
Table 4 - continuation
Table 5 – Determination of the factors associated with hypertension in people with acquired immune deficiency 
syndrome under antiretroviral therapy, after control of the possible confounding variables (n = 36). Fortaleza, Ceará, 
Brazil, 2015-2017
Factor Crude odds ratio Adjusted odds ratio 95% CI* Significance (Wald’s test)
Age
> 45 years 2.97 2.95 1.30 – 6.70 P = 0.010
≤ 45 years 1 1
Family history of hypertension
Yes 4.51 5.12 1.64 – 15.98 P = 0.005
No 1 1
Overweight (BMI† ≥ 25)
Yes 2.35 2.74 1.18 – 6.36 P = 0.019
No 1 1
Time of antiretroviral therapy
> 36 months 5.52 4.99 1.77 – 14.05 P = 0.002
≤ 36 months 1 1
*CI: confidence interval; †BMI: body mass index
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Discussion
Most of the sample of this study were men, 
corroborating with other studies, showing that HIV is 
still affecting more men than women(17-18). People of 
darker skin color were highlighted in the analyses, and 
in this regard, a study conducted in the United States 
also pointed that the absolute number of Caucasians 
with an aids diagnosis is much lower when compared to 
African Americans; however, there is a tendency in the 
number of people with aids increasing among Caucasian 
individuals when compared to African Americans(19).
The patients’ schooling was relatively high, similar 
to the findings of other studies(20-21). People with higher 
education level may have more access to relevant 
health information, presenting a broader perception on 
cardiovascular risk factors and the need to maintain 
a healthy lifestyle(22). Singles were the majority of 
patients and, given this, our study showed that single 
people are more likely to have multiple partners, thus 
becoming more vulnerable to HIV(23). However, the 
increase in the number of HIV infection cases among 
people in stable relationships must be highlighted; this 
derives from the lack of negotiation about condom use, 
especially by females(24).
Participants whom did not had children were the 
majority. On this aspect, a study showed that the care 
demands of several children, especially if they are 
young, can lead to problems in the treatment routine, 
due to competing needs from the children’s routine(25). 
Regarding religion, most participants reported to be 
Catholic. Regardless of belief, this study found that 
religion helps people with aids in adhering to the ART 
and in the fight against the disease, but it must be 
noted that mistakes can happen and some patients 
may start assigning the treatment and cure of aids to 
religion, not properly adhering to the ART and other 
health guidelines(26).
Most patients were employed during the study 
period. Having a steady job can help people with aids to 
replace their identity as patients, since those who work 
report significant improvements in their quality of life 
when compared to those who are unemployed; however, 
usually the main cause of cessation of work is the 
stigma resulting from the disease(27). Sexual exposure 
and heterosexuality were relevant in the analyses, 
contrasting the beginnings of the epidemic, when most 
people affected were homosexuals, users of intravenous 
drugs and people who underwent blood transfusions(1). 
A considerable number of patients had lipodystrophy. 
Considering this information, a research showed that 
adherence to ART tends to decrease over time after the 
lipodystrophy diagnosis(28).
The antiretroviral drugs used the most were 
lamivudine, tenofovir efavirenz and zidovudine. 
Considering these drugs, nucleoside analogue reverse 
transcriptase inhibitors such as lamivudine, zidovudine 
and tenofovir, may cause mitochondrial and liver toxicity, 
lipoatrophy, anemia, myopathy, peripheral neuropathy 
and pancreatitis. On the other hand, non-nucleoside 
analogue reverse transcriptase inhibitors like efavirenz, 
may elevate liver enzymes, cause dyslipidemia, 
exanthema and Stevens-Johnson syndrome(29).
Regarding the risk factors for hypertension, most 
aids patients presented moderate salt consumption and 
some used salt shaker on the table during meals. Low 
salt consumption and not using a salt shaker on the 
table are hypertension prevention strategies that must 
be adopted by everyone(30). Many patients ate fried and 
fatty foods, which can lead to obesity and cardiovascular 
diseases(31). Some participants used alcohol and 
smoked, which is also related to the development of 
cardiovascular diseases(32-33). Most had family history 
of hypertension, diabetes mellitus and did not practice 
physical exercises.
In this study, the prevalence of hypertension 
among people with aids was 17.3%. However, data on 
prevalence of hypertension among this type of patient 
are variable. A survey found 19.3% prevalence of people 
with aids before starting ART, but after 12 months of 
ART initiation, 31% of the patients were hypertensive(34). 
In another study, the prevalence ranged from 4.7% 
and 54.4% in high-income countries and from 8.7% to 
45.9% in middle-income countries(6). Another research 
found prevalence of hypertension in 38% of people with 
aids under ART, and 19% in people whom were not 
under such therapy(4).
In this study, the antihypertensive drugs most 
frequently used by people with aids were losartan, 
hydrochlorothiazide and enalapril.It was found that 
people with aids and hypertension had higher mean age, 
greater circumference waist, longer time of infection and 
longer time of use of ART.
Patients with aids had higher chances of presenting 
hypertension when the age was greater than 45 years, 
had family history of hypertension, were overweight, 
had increased waist circumference and time of use 
of ART greater than 36 months. Logistic regression 
analysis showed that the risk of hypertension increased 
according to age greater than 45 years, family history of 
hypertension, being overweight and time of use of ART.
We can assume that the incidence of cardiovascular 
diseases in people with aids increases due to the 
profile of high risk factors and increased the survival 
rate of these patients. Therefore, the estimation of 
cardiovascular risk and the management of these risk 
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factors among individuals with aids must be part of the 
regular treatment approach(35).
Considering the limitations of the study, one of them 
was not thoroughly verifying what types of antiretroviral 
drugs were more associated with hypertension, because 
all aids patients used a combination of distinct classes 
of antiretroviral drugs. Another relevant aspect would 
be the inclusion of a control group of patients with aids 
whom were not under ART. This was not possible due 
to recent guidelines for the treatment of people with 
aids, which advocate the use of ART as soon as possible 
after the positive diagnosis of anti-HIV serology, as 
a measure to decrease the morbidity and mortality 
among these patients.
Conclusion
This study concludes that the prevalence of people 
with aids and hypertension was 17.3%. In the studied 
sample, patients with aids and hypertension were older 
than 45 years, had family history of hypertension, 
were overweight (BMI ≥ 25), had increased waist 
circumference and used ART for more than 36 months. 
Finally, the logistic regression analysis confirmed the 
influence of age greater than 45 years, family history 
of hypertension, being overweight (BMI ≥ 25) and 
use of ART for more than 36 months in the process 
of hypertension of patients with aids assessed in this 
research.
We emphasize the importance of this study, given 
that ART reduced the morbidity and mortality of people 
with aids, providing greater survival rates. Therefore, the 
analysis of diseases that affect the general population is 
important among people with aids, seeking to provide a 
better quality of life for these individuals.
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